Click here to read or download the Annual Report.
Four runners have received Appreciation Awards for supporting Hepatitis B Foundation UK.
NICE has announced that BaracludeŽ (entecavir) is recommended as an option for treatment of eligible patients with chronic hepatitis B.
It's still not too late to support Team Hepatitis B Foundation UK!
We need critical readers to review the draft leaflet and give comments.
We need people to join our Patients' Advisory Group.
